Shares shifted sharply higher after a rare convergence of Wall Street, Silicon Valley, and Washington catalysts landed on IBM within 48 hours — forcing investors to re-examine whether the 115-year-old company deserves a richer valuation.

JPMorgan Says the Market Is Mispricing IBM's Software Profits

JPMorgan upgraded IBM from Neutral to Overweight, raising its price target from $270 to $291 . The core argument: software now makes up about 45% of IBM's total revenue yet commands roughly two-thirds of its consolidated profits . Analyst Brian Essex cited accelerating software momentum in the second half of 2026 as the key driver . In plain English, if investors start valuing IBM based on its higher-profit software business rather than its legacy hardware reputation, the stock could trade at a steeper premium. Morgan Stanley also raised its target to $267 from $225 , suggesting growing Street-wide confidence. Still, shares have fallen nearly 15% year to date , so skeptics remain.

An OpenAI Partnership Puts IBM in the AI Security Spending Lane

IBM joined the OpenAI Daybreak Cyber Partner Program, bringing frontier AI capabilities into security operations to help enterprises counter machine-speed threats . The initiative feeds into Project Lightwell, backed by a $5 billion commitment from IBM and Red Hat . This matters because cybersecurity budgets are among the last things corporations cut in a downturn. By plugging OpenAI's models into enterprise code review, IBM pulls deeper into high-value cybersecurity spend that budgets tend to protect .

Washington Is Writing Checks — and IBM Is the Biggest Recipient

Federal quantum funding allocations direct roughly $1 billion to IBM, $375 million to GlobalFoundries, and $100 million each to D-Wave, Rigetti, and Infleqtion . President Trump signed two executive orders targeting deployment of a research-capable quantum computer by 2028 and mandating federal migration to quantum-resistant encryption by 2031 . IBM CEO Arvind Krishna attended the Oval Office signing alongside Alphabet's president . The encryption mandate alone could create a multiyear federal procurement cycle in which IBM's existing quantum-safe cryptography tools give it a head start.

The Open Question for Shareholders The rally reflects genuine catalysts, but execution risk looms. IBM's $11 billion Confluent acquisition is still being integrated, the stock remains down about 15% in 2026 , and quantum revenue remains largely pre-commercial. Investors are betting on the direction of the business mix — not yet the destination.